Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Jay Hsu"'
Publikováno v:
Neurology and Therapy, Vol 10, Iss 1, Pp 121-147 (2020)
Abstract Introduction A post hoc analysis of a double-blind (DB) active control trial and an open-label extension (OLE) study was conducted to evaluate the long-term effects of lurasidone in patients with schizophrenia. Methods In the DB trial, patie
Externí odkaz:
https://doaj.org/article/79852fc5e1a4400cb093be96817c3579
Publikováno v:
European Psychiatry, Vol 65 (2022)
AbstractBackgroundTo evaluate the efficacy of short-term lurasidone in antipsychotic treatment-naïve (TN) adolescents with schizophrenia versus those treated previously (TP) with antipsychotics.MethodsPatients aged 13–17 with schizophrenia, and a
Externí odkaz:
https://doaj.org/article/2d35ce8c927b4012a576510464af9135
Autor:
Isabella Costamagna, Fabrizio Calisti, Agnese Cattaneo, Jay Hsu, Michael Tocco, Andrei Pikalov, Robert Goldman
Publikováno v:
European Psychiatry, Vol 64 (2021)
Abstract Background The aim of this pooled analysis was to evaluate the efficacy and safety of lurasidone in the treatment of an acute exacerbation of schizophrenia in adolescents and young adults. Methods The six pooled studies in this analysis u
Externí odkaz:
https://doaj.org/article/6d71dcd0347e4dfcabdaeece301ac3db
Publikováno v:
Schizophrenia Research. 240:205-213
There is a relative lack of long-term, prospective data evaluating the safety and effectiveness of treatment in early-onset adolescent patients with schizophrenia who are treatment-naïve. The aim of this post-hoc analysis was to examine the long-ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e0e368f6190463aec9afb83933d842b
https://doi.org/10.1016/j.schres.2021.12.046
https://doi.org/10.1016/j.schres.2021.12.046
Autor:
Kenneth S. Koblan, Jay Hsu, Justine Kent, Lenard A. Adler, Seth C. Hopkins, Robert Goldman, Antony Loebel
Publikováno v:
International Clinical Psychopharmacology. 36:117-125
In a previous study, dasotraline demonstrated efficacy at a dose of 8 mg/day in adults with attention deficit hyperactivity disorder (ADHD). The aim of the current study was to evaluate the efficacy and safety of dasotraline in doses of 4 and 6 mg/da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bc3431c614f25371e2e01693ab08cc8
https://doi.org/10.1097/yic.0000000000000333
https://doi.org/10.1097/yic.0000000000000333
Publikováno v:
Neurology and Therapy, Vol 10, Iss 1, Pp 121-147 (2020)
Neurology and Therapy
Neurology and Therapy
Introduction A post hoc analysis of a double-blind (DB) active control trial and an open-label extension (OLE) study was conducted to evaluate the long-term effects of lurasidone in patients with schizophrenia. Methods In the DB trial, patients were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e02a5fe61d190e5ac847984c4b11b6
https://doaj.org/article/79852fc5e1a4400cb093be96817c3579
https://doaj.org/article/79852fc5e1a4400cb093be96817c3579
Autor:
Ann C. Childress, Justine Kent, Kenneth S. Koblan, Sharon B. Wigal, Robert Goldman, Antony Loebel, Seth C. Hopkins, Joyce Tsai, Jay Hsu
Publikováno v:
Journal of Attention Disorders
Objective: To evaluate the efficacy and safety of dasotraline for treatment of ADHD in children. Method: Children (ages 6-12 years; N = 112) with ADHD were randomized, double-blind, to 14 days of once-daily evening doses of dasotraline 4 mg or placeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd23a3eefb47da6d7cf6d9101fa8473
https://doi.org/10.1177/1087054719864644
https://doi.org/10.1177/1087054719864644
Autor:
Andrei Pikalov, Michael Tocco, Robert Goldman, Isabella Costamagna, Jay Hsu, Fabrizio Calisti, Agnese Cattaneo
Publikováno v:
European Psychiatry
Background The aim of this pooled analysis was to evaluate the efficacy and safety of lurasidone in the treatment of an acute exacerbation of schizophrenia in adolescents and young adults. Methods The six pooled studies in this analysis used similar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834cfac755e771c40a334d7f85d6a2b9
https://doi.org/10.1192/j.eurpsy.2021.30
https://doi.org/10.1192/j.eurpsy.2021.30
Publikováno v:
European Neuropsychopharmacology. 40:S473-S474
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::471b828795c15b7552d7827139efe38f
https://doi.org/10.1016/j.euroneuro.2020.09.615
https://doi.org/10.1016/j.euroneuro.2020.09.615
Publikováno v:
CNS Spectrums. 25:267-268
Background:Early-onset schizophrenia is characterized by greater severity and more functional impairment than adult-onset schizophrenia. Few studies have prospectively evaluated short- or long-term antipsychotic efficacy in treatment-naïve (vs. prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c23e2b1da6dde69a82b302f12fd6cc6
https://doi.org/10.1017/s109285292000022x
https://doi.org/10.1017/s109285292000022x